Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
250.10
+2.79 (1.13%)
At close: May 21, 2026

SHA:688506 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,9675,1773,220403.961,005154.22
Short-Term Investments
-2,5042,533---
Trading Asset Securities
2,0582,159----
Cash & Short-Term Investments
5,0259,8405,753403.961,005154.22
Cash Growth
37.00%71.04%1324.16%-59.79%551.49%-36.99%
Accounts Receivable
83.37100.35138.71137.85267.92134.95
Other Receivables
17.4219.434.333.95.142.95
Receivables
100.79119.75173.05141.75273.06137.9
Inventory
144.68146.31162.19140.91101.3382.33
Other Current Assets
4,735384.42218.8789.247.2249.36
Total Current Assets
10,00610,4916,307775.821,426423.81
Property, Plant & Equipment
876.64816.31573.09534.79420.26404.98
Other Intangible Assets
29.9930.326.682829.5331.16
Long-Term Deferred Tax Assets
53.5638.21179.276.1883.2365.8
Long-Term Deferred Charges
29.0830.4618.41.821.791.16
Other Long-Term Assets
50.5841.7932.798.530.2824.54
Total Assets
11,04611,4487,1371,4251,991951.46
Accounts Payable
603.15206.83219.25160.17128.8545.96
Accrued Expenses
70.6621.31437.25257.88244.81139.81
Short-Term Debt
-100.08595.5275.12155.13161.23
Current Portion of Long-Term Debt
-841.49235.28174.3730.470.02
Current Portion of Leases
-23.912.4646.1368.8224.23
Current Income Taxes Payable
--14.130.014.961.54
Current Unearned Revenue
7.257.31356.138.6717.4210.78
Other Current Liabilities
1,319137.74109.94131.4886.7487.75
Total Current Liabilities
2,0001,9391,9801,054737.2471.32
Long-Term Debt
3,1102,6161,189183.92239.9650
Long-Term Leases
141.26132.828.138.6552.9551.42
Long-Term Unearned Revenue
123.91125.8242.2715.6313.2931.04
Long-Term Deferred Tax Liabilities
18.024.321.94-0.08-
Other Long-Term Liabilities
8.227.589.7311.1914.0515.81
Total Liabilities
5,4024,8253,2511,2731,058619.61
Common Stock
412.87412.87401401401360.9
Additional Paid-In Capital
4,6704,659885.84858.69858.5514.17
Retained Earnings
770.381,5452,599-1,109-328.45-45.98
Comprehensive Income & Other
-10.015.50.531.132.792.76
Total Common Equity
5,6446,6233,886151.87933.89331.85
Shareholders' Equity
5,6446,6233,886151.87933.89331.85
Total Liabilities & Equity
11,04611,4487,1371,4251,991951.46
Total Debt
3,2523,7142,061688.19547.33286.91
Net Cash (Debt)
1,7736,1263,692-284.23457.41-132.69
Net Cash Growth
111.81%65.91%----
Net Cash Per Share
4.3615.189.21-0.711.26-0.37
Filing Date Shares Outstanding
412412.87401401401360.9
Total Common Shares Outstanding
412412.87401401401360.9
Working Capital
8,0068,5524,327-278.01689.14-47.51
Book Value Per Share
13.7016.049.690.382.330.92
Tangible Book Value
5,6146,5923,859123.88904.36300.69
Tangible Book Value Per Share
13.6315.979.620.312.260.83
Buildings
-323.1325.3304.56302.23300.82
Machinery
-717.87640.12554.25439.83419.75
Construction In Progress
-115.835.5181.3767.2118.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.